Metabolic tumor parameters on 18F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma
Shuhui Huang, Yaowen Zhang, Wei Zhang, Tian Tian, Hongyuan Dai, Mengfang Qi et al. Metabolic tumor parameters on 18F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma. // Annals of Nuclear Medicine. – 2025. – DOI: 10.1007/s12149-025-02039-2. – URL: https://doi.org/10.1007/s12149-025-02039-2
Shuhui Huang, Yaowen Zhang, Wei Zhang, Tian Tian, Hongyuan Dai, Mengfang Qi, Minggang Su, Hao Zeng, & Rui Huang (2025). Metabolic tumor parameters on 18F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-025-02039-2
Shuhui Huang, et al. “Metabolic tumor parameters on 18F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.” Annals of Nuclear Medicine, 2025. doi:10.1007/s12149-025-02039-2.
@article{Huang2025,
title = {Metabolic tumor parameters on 18F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma},
author = {Huang, Shuhui and Zhang, Yaowen and Zhang, Wei and Tian, Tian and Dai, Hongyuan and Qi, Mengfang and Su, Minggang and Zeng, Hao and Huang, Rui},
journal = {Annals of Nuclear Medicine},
year = {2025},
doi = {10.1007/s12149-025-02039-2},
url = {https://doi.org/10.1007/s12149-025-02039-2}
}